VEXAS Syndrome-A Review of Pathophysiology, Presentation, and Prognosis
- PMID: 36251488
- DOI: 10.1097/RHU.0000000000001905
VEXAS Syndrome-A Review of Pathophysiology, Presentation, and Prognosis
Abstract
VEXAS ( V acuoles, E 1 enzyme, X -linked, A utoinflammatory, S omatic) syndrome is a newly identified disease caused by somatic mutations in the UBA1 gene resulting in refractory autoinflammatory features, frequently accompanied by cytopenias. Although the prevalence of this syndrome is yet unknown, understanding the clinical phenotype can assist clinicians in prompt recognition of cases among patients with glucocorticoid-responsive but immunosuppressive-resistant inflammatory symptoms. The pathophysiology, clinical presentation, diagnostic methods, treatment, and prognosis of VEXAS are herein reviewed.
Trial registration: ClinicalTrials.gov NCT05027945.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- French FMFC. A candidate gene for familial Mediterranean fever. Nat Genet . 1997;17:25–31.
-
- Nigrovic PA, Lee PY, Hoffman HM. Monogenic autoinflammatory disorders: conceptual overview, phenotype, and clinical approach. J Allergy Clin Immunol . 2020;146:925–937.
-
- Zhou Q, Aksentijevich I, Wood GM, et al. Brief report: cryopyrin-associated periodic syndrome caused by a myeloid-restricted somatic NLRP3 mutation. Arthritis Rheumatol . 2015;67:2482–2486.
-
- Rowczenio DM, Trojer H, Omoyinmi E, et al. Brief report: association of tumor necrosis factor receptor-associated periodic syndrome with gonosomal mosaicism of a novel 24-nucleotide TNFRSF1A deletion. Arthritis Rheumatol . 2016;68:2044–2049.
-
- De Inocencio J, Mensa-Vilaro A, Tejada-Palacios P, et al. Somatic NOD2 mosaicism in Blau syndrome. J Allergy Clin Immunol . 2015;136:484–487 e482.
Publication types
MeSH terms
Substances
Supplementary concepts
Associated data
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous